Atlas Trials

R-CMOP in Patients With Primary Diffuse Large B-cell Lymphoma

Clinical trial NCT05777369 · UNKNOWN

Trial details

NCT number
NCT05777369
Sponsor
The First Affiliated Hospital with Nanjing Medical University
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Diffuse Large B-cell Lymphoma
Start date
2023-03-01
Primary completion
2023-08-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.